WKY.SHR-(D1Wox19-D1Mit2)/Njs |
systolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
144.0 |
mmHg |
1.9 |
8.5 |
vascular indwelling catheter method |
|
|
0 |
beat to beat for 1 hour |
11325 |
72 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
systolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 29 |
continuous mean |
178.8 |
mmHg |
2.32 |
12.5 |
vascular indwelling catheter method |
aorta |
|
0 |
|
11905 |
206 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
175 days
| 20 |
|
0.61 |
mg/dl |
0.03 |
0.11 |
automated blood analysis |
|
0.0 |
0 |
|
67761 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma urea nitrogen level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
35 days
| 19 |
|
4.38 |
mmol/l |
0.17 |
0.73 |
automated blood analysis |
|
0.0 |
0 |
|
67769 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
140 days
| 29 |
continuous mean |
133.4 |
mmHg |
1.39 |
7.5 |
tail cuff plethysmography |
|
|
0 |
animals were prewarmed to 34 degrees C for 20 min before BP |
65085 |
206 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
body weight |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
body mass |
male |
175 days
| 20 |
|
343.1 |
g |
6.02 |
26.9 |
body weighing method |
|
|
0 |
|
11642 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
left kidney wet weight |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
kidney mass |
male |
175 days
| 20 |
|
1.25 |
g |
0.06 |
0.25 |
post excision weight measurement |
|
|
0 |
|
11644 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
mean arterial blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
140 days
| 20 |
|
130.9 |
mmHg |
0.67 |
3.0 |
tail cuff photoplethysmography |
|
0.0 |
0 |
3 times on 2 days |
11317 |
72 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
diastolic blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
175 days
| 29 |
continuous mean |
113.7 |
mmHg |
1.75 |
9.4 |
vascular indwelling catheter method |
aorta |
|
0 |
|
11906 |
206 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
diastolic blood pressure |
control condition |
Frantz S, et al., Hypertension 2001 Aug;38(2):216-21 |
arterial blood pressure trait |
male |
196 days
| 20 |
|
116.3 |
mmHg |
2.24 |
10.0 |
vascular indwelling catheter method |
|
|
0 |
beat to beat for 1 hour |
11333 |
72 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
systolic blood pressure |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
arterial blood pressure trait |
male |
42 days
| 19 |
|
94.1 |
mmHg |
0.53 |
2.3 |
tail cuff photoplethysmography |
|
0.0 |
0 |
|
67767 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma creatinine level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood creatinine amount |
male |
35 days
| 19 |
|
0.45 |
mg/dl |
0.02 |
0.08 |
automated blood analysis |
|
0.0 |
0 |
|
67771 |
110 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
mean arterial blood pressure |
control condition |
Frantz SA, et al., Hypertension 1998 Oct;32(4):639-46 |
arterial blood pressure trait |
male |
112 days
| 29 |
continuous mean |
127.3 |
mmHg |
1.6 |
8.6 |
tail cuff plethysmography |
|
0 |
0 |
animals were prewarmed to 34 degrees C for 20 min before BP |
65081 |
206 |
WKY.SHR-(D1Wox19-D1Mit2)/Njs |
plasma urea nitrogen level |
control condition |
Clemitson JR, et al., Hypertension 2002 Sep;40(3):292-7 |
blood urea nitrogen amount |
male |
175 days
| 20 |
|
5.16 |
mmol/l |
0.12 |
0.55 |
automated blood analysis |
|
0.0 |
0 |
|
67753 |
110 |